Oct 3 |
Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
|
Sep 17 |
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
|
Aug 14 |
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
|
Aug 6 |
Omega Therapeutics GAAP EPS of -$0.30, revenue of $2.13M
|
Aug 6 |
Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue Estimates
|
Aug 6 |
Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
|
Aug 6 |
Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner
|
Jun 24 |
Omega Therapeutics Announces Election of Richard N. Kender to Board of Directors
|
Jun 19 |
Nurix Therapeutics (NRIX) Surges 20.6%: Is This an Indication of Further Gains?
|
Jun 18 |
Raymond James starts Omega at outperform, cites platform
|